石汉平教授带领的研究团队，主要致力于从事胃肠道肿瘤手术治疗、肿瘤综合治疗、癌性肠梗阻治疗、临床营养治疗、肿瘤代谢调节治疗、保功能盆腔廓清、肠瘘、生酮治疗、肿瘤代谢与营养研究。团队发表学术论文近600余篇，其中SCI论文一百多篇。 主编了我国第一部《围手术期病理生理与临床》、《肿瘤营养学》、《营养筛查与评估》、《肿瘤恶液质》、《中国肿瘤营养治疗指南》、《蛋白质临床应用》、《临床营养操作规程》等重要学术专著近20部，参与编写国家统编教材5部，参与编写其他学术专著近50部。

团队获得国家重点研发计划项目2项、国家自然科学基金7项，省部级课题20余项。团队所在科室是肿瘤代谢与营养工程中心、癌性肠梗阻中心、全国规范化肿瘤营养治疗示范病房，是《Journal of Nutritional Oncology》、《Precision Nutrition》、《肿瘤代谢与营养电子杂志》(核心期刊)及《医学参考报—营养学频道》主编单位及编辑部所在地。

 团队领衔在全国开展了《中国肿瘤营养规范化培训项目----肿瘤营养疗法，CNT》、《癌性肠梗阻学习班》。

团队成员每年应邀出席学术讲座近200次，与美国约翰斯•霍普金斯大学、耶鲁大学、杜克大学、加州大学洛杉矶分校、范德堡大学、阿拉巴马大学、罗格大学、华盛顿州立大学、乔治城大学保持着密切的学术交流与人员交往。

1.中国科学技术协会--2016承接政府转移职能与科技公共服务工程（2016.04-2016.12，项目编号2016GGFZ001）全国规范化肿瘤营养示范病房

2.国家卫计委--食品安全国家标准（2016.11.24-2017.10.31,项目编号spaq-2016-119）肿瘤全营养配方食品

3.国家自然科学基金项目（2017.01-2019.12，项目编号81672888）LncRNA-421627增强mTORC1-HIF1代谢重编程促进结肠癌转移

4.国家重点研发计划项目（2017.07-2021.06，项目编号2017YFC1309200，800万）恶性肿瘤姑息治疗和护理关键技术研究

5.北京市科学技术委员会（2018.01-2021.12，项目编号SCW2018-06，335万）北京社区及医疗机构老年人群健康状态综合评估量表的研发、评估及应用研究

6.首都医科大学临床医学高精尖学科建设项目----首都医科大学与北京协和医学院共建项目（2019.01-2021.12，项目编号1192070317，经费30万）癌性肠梗阻

7.肿瘤代谢与营养北京市国际科技合作基地（BeijingInternational Science and Technology Cooperation Base for CancerMetabolism and Nutrition）。北京市科学技术委员会，2018年

8. 特殊医学用途肿瘤全营养配方食品技术审评规程研究。国家市场监督管理总局。2020年7月1日至2020年12月31日，10万

9. 首都医科大学2020临床医学高精尖学科共建项目（2020.10-2021.03，项目编号1202100313，金额7万）癌性肠梗阻的临床治疗及应用

10.国家重点研发计划项目（2022.5-2025.5,项目编号2022YFC2009600，金额1982万）临床实验室检验新技术与参考系统建立应用研究

队列研究

1.常见恶性肿瘤营养状况与临床结局相关性研究（Investigation on Nutrition Status and itsClinical Outcome of Common Cancers，INSCOC，ChiCTR180002032）

2.生活方式医学干预改善肿瘤患者结局研究（Personalized lifestyle Medicine to Improve Outcome for Patient with Cancer，LIOC，ChiCTR2100044548）

3.中国精准营养与健康KAP真实世界研究（China Precision Nutrition and Health- KAP Real World Study，CPN-KAPS，ChiCTR2100051983）

1.      XieH, Ruan G, Ge Y, Zhang Q,Zhang H, Lin S, Song M, Zhang X, Liu X, Li X, Zhang K,Yang M, Tang M, Song CH,Shi H. Inflammatory burden as a prognostic biomarkerfor cancer. ClinNutr. 2022 Jun;41(6):1236-1243. (IF: 7.324)

2.      LiuT, Zhang Q, Song C, SiyinST, Chen S, Zhang Q, Song M, Cao L, Shi H. C-reactiveproteintrajectories and the risk of all cancer types: A prospective cohortstudy. IntJ Cancer. 2022 Jul 15;151(2):297-307. (IF: 7.396)

3.      XieH, Ruan G, Deng L, Zhang H,Ge Y, Zhang Q, Lin S, Song M, Zhang X, Liu X, Li X,Zhang K, Yang M, Tang M, HuW, Weng M, Shi H. Comparison of absolute andrelative handgrip strengthto predict cancer prognosis: A prospectivemulticenter cohort study. Clin Nutr.2022 Aug;41(8):1636-1643. (IF: 7.324)

4.      FuZ, Zhang R, Wang KH, CongMH, Li T, Weng M, Guo ZQ, Li ZN, Li ZP, Wang C, Xu HX,Song CH, Zhuang CL,Zhang Q, Li W, Shi HP; INSCOC Study Group. Development andvalidation ofa Modified Patient-Generated Subjective Global Assessment as anutritionalassessment tool in cancer patients. J Cachexia Sarcopenia Muscle.2022Feb;13(1):343-354. (IF: 12.910)

5.      SongM, Zhang Q, Song C, Liu T,Zhang X, Ruan G, Tang M, Xie H, Zhang H, Ge Y, Li X,Zhang K, Yang M, Li Q, LiuX, Lin S, Xu Y, Xu H, Wang K, Li W, Shi H. Theadvanced lung cancerinflammation index is the optimal inflammatory biomarker ofoverall survival inpatients with lung cancer. J Cachexia Sarcopenia Muscle.2022 Jul 14. (IF: 12.910)

6.      RuanGT, Xie HL, Zhu LC, Ge YZ,Yan L, Liao C, Gong YZ, Shi HP. Immune ULBP1 isElevated in ColonAdenocarcinoma and Predicts Prognosis. Front Genet. 2022 Feb8;13:762514. (IF:4.599)

7.      LiuYY, Ruan GT, Ge YZ, Li QQ,Zhang Q, Zhang X, Tang M, Song MM, Zhang XW, Li XR,Zhang KP, Yang M, Hu CL,Liu T, Xie HL, Liu XY, Lin SQ, Weng M, Yao QH, Wang ZP,Cong MH, Shi HP.Systemic inflammation with sarcopenia predicts survival inpatients withgastric cancer. J Cancer Res Clin Oncol. 2022 Apr 18. (IF: 4.553)

8.      LiuT, Fan Y, Zhang Q, Wang Y,Yao N, Song M, Zhang Q, Cao L, Song C, Shi H. Thecombination ofmetabolic syndrome and inflammation increased the risk ofcolorectal cancer.Inflamm Res. 2022 Aug;71(7-8):899-909. (IF: 4.575)

9.      YangM, Zhang Q, Ge Y, Tang M,Hu C, Wang Z, Zhang X, Song M, Ruan G, Zhang X, Liu T,Xie H, Zhang H, Zhang K,Li Q, Li X, Liu X, Lin S, Shi H. Prognostic Roles ofInflammation- andNutrition-Based Indicators for Female Patients with Cancer. JInflamm Res. 2022Jun 17;15:3573-3586. (IF: 6.922)

10.   SongM, Li Y, Chen Z, Zhang J,Yang L, Zhang F, Song C, Miao M, Chang W, Shi H. TheLong Non-Coding RNAFAM222A-AS1 Negatively Modulates MiR-Let-7f to PromoteColorectal CancerProgression. Front Oncol. 2022 May 12;12:764621. (IF: 6.244)

11.   CongM, Song C, Xu H, Song C,Wang C, Fu Z, Ba Y, Wu J, Xie C, Chen G, Chen Z, ZhouL, Li T, Deng L, Xin L,Yang L, Cui J, Shi H; Investigation on Nutrition Statusand ClinicalOutcome of Common Cancers (INSCOC) Group. The patient-generatedsubjectiveglobal assessment is a promising screening tool for cancer cachexia.BMJSupport Palliat Care. 2022 May;12(e1):e39-e46. (IF: 3.568)

12.   RuanGT, Xie HL, Zhang HY, LiuCA, Ge YZ, Zhang Q, Wang ZW, Zhang X, Tang M, Song MM,Zhang XW, Yang M, ChenYB, Yu KY, Deng L, Gong YZ, Hu W, Wang KH, Cong MH, ShiHP. A NovelInflammation and Insulin Resistance Related Indicator to Predict theSurvival ofPatients With Cancer. Front Endocrinol (Lausanne). 2022 Jun 20;13:905266.(IF:5.555)

13.   RuanGT, Xie HL, Deng L, Ge YZ,Zhang Q, Wang ZW, Zhang X, Zhang HY, Tang M, Song MM,Zhang XW, Yang M, Pan L,Wang KH, Cong MH, Gong YZ, Wang MY, Shi HP. A NovelSystemicInflammation Prognostic Score to Stratify Survival in Elderly PatientsWithCancer. Front Nutr. 2022 Jul 5;9:893753. doi: 10.3389/fnut.2022.893753.PMID:35866083; PMCID: PMC9294408. (IF: 6.576)

14.   RuanX, Wang X, Zhang Q,Nakyeyune R, Shao Y, Shen Y, Niu C, Zhu L, Zang Z, Wei T,Zhang X, Ruan G, SongM, Miles T, Liu F, Shi H; Investigation on NutritionStatus and ClinicalOutcome of Common Cancers (INSCOC) Group. The performance ofthree nutritionaltools varied in colorectal cancer patients: a retrospectiveanalysis. J ClinEpidemiol. 2022 May 7;149:12-22. (IF: 6.437)

15.   ZhangX, Li X, Shi H, Zhang K,Zhang Q, Tang M, Li W, Zhou F, Liu M, Cong M, Shi H.Association of thefat-free mass index with mortality in patients with cancer: Amulticenterobservational study. Nutrition. 2022 Feb;94:111508. (IF: 4.008)

16.   ZhangXW, Zhang Q, Song MM,Zhang KP, Zhang X, Ruan GT, Yang M, Ge YZ, Tang M, Li XR,Wang KH, Shi HP.The prognostic effect of hemoglobin on patients with cancercachexia: amulticenter retrospective cohort study. Support Care Cancer.2022Jan;30(1):875-885. (IF: 3.603)

17.   LiuCA, Zhang Q, Ruan GT, ShenLY, Xie HL, Liu T, Tang M, Zhang X, Yang M, Hu CL,Zhang KP, Liu XY, Shi HP.Novel Diagnostic and Prognostic Tools for Lung CancerCachexia: Based onNutritional and Inflammatory Status. Front Oncol. 2022 Jul11;12:890745. (IF:6.244)

18.   RuanGT, Xie HL, Gong YZ, GeYZ, Zhang Q, Wang ZW, Zhang X, Zhang HY, Tang M, SongMM, Zhang XW, Yang M,Chen YB, Yu KY, Deng L, Wang KH, Cong MH, Shi HP.Prognostic importanceof systemic inflammation and insulin resistance inpatients with cancer: aprospective multicenter study. BMC Cancer. 2022 Jun25;22(1):700. (IF: 4.430)

19.   RuanGT, Ge YZ, Xie HL, Hu CL,Zhang Q, Zhang X, Tang M, Song MM, Zhang XW, Liu T, LiXR, Zhang KP, Yang M, LiQQ, Chen YB, Yu KY, Braga M, Cong MH, Wang KH,Barazzoni R, Shi HP.Association Between Systemic Inflammation and MalnutritionWith Survival inPatients With Cancer Sarcopenia-A Prospective MulticenterStudy. Front Nutr.2022 Feb 7;8:811288. (IF: 6.576)

20.   ZhangX, Zhang Q, Tang M, ZhangKP, Zhang XW, Song MM, Ruan GT, Sun Q, Li W, Xu HX,Cong MH, Deng L, Shi HP.Nutrition-inflammation marker enhances prognostic valueto ECOG performancestatus in overweight or obese patients with cancer. JPEN JParenter EnteralNutr. 2022 May 19. (IF: 4.016)

21.   LiuT, Song C, Zhang Y, SiyinST, Zhang Q, Song M, Cao L, Shi H. Hepatitis B virusinfection and therisk of gastrointestinal cancers among Chinese population: Aprospective cohortstudy. Int J Cancer. 2022 Mar 15;150(6):1018-1028. (IF:7.396)

22.   GeYZ, Ruan GT, Zhang Q, DongWJ, Zhang X, Song MM, Zhang XW, Li XR, Zhang KP, TangM, Li W, Shen X, ShiHP; Investigation on the Nutrition Status and ClinicalOutcome of CommonCancers (INSCOC) Group. Extracellular water to total bodywater ratio predictssurvival in cancer patients with sarcopenia: a multi-centercohort study. NutrMetab (Lond). 2022 May 7;19(1):34. (IF: 4.169)

23.   YangM, Zhang Q, Ge YZ, Tang M,Hu CL, Wang ZW, Zhang X, Song MM, Ruan GT, Zhang XW,Liu T, Xie HL, Zhang HY,Zhang KP, Li QQ, Li XR, Liu XY, Lin SQ, Shi HP.Prognostic Roles ofGlucose to Lymphocyte Ratio and Modified Glasgow PrognosisScore in PatientsWith Non-small Cell Lung Cancer. Front Nutr. 2022 May10;9:871301. (IF: 6.576)

24.   LiXR, Zhang Q, Zhang KP, ZhangX, Ruan GT, Song MM, Ge YZ, Zhang XW, Song CH, ShiHP. Association ofserum total bilirubin with survival outcomes in patients withcancer cachexia:A prospective, multicenter cohort study. Nutrition. 2022 Apr30;102:111711. (IF:4.008)

25.   XieH, Ruan G, Zhang H, ZhangQ, Ge Y, Song M, Zhang X, Lin S, Liu X, Liu Y, ZhangX, Li X, Zhang K, Yang M,Tang M, Li Z, Shi H. Association of Modified GeriatricNutrition RiskIndex and Handgrip Strength With Survival in Cancer: AMulti-Centre CohortStudy. Front Nutr. 2022 Apr 1;9:850138. (IF: 6.576)

26.   XieH, Ruan G, Zhang Q, Ge Y,Song M, Zhang X, Liu X, Lin S, Zhang X, Li X, Zhang K,Yang M, Tang M, Cong M,Shi H. Combination of Nutritional Risk Index andHandgrip Strength on theSurvival of Patients with Cancer Cachexia: A Multi-Center Cohort Study. JInflamm Res. 2022 Feb 15;15:1005-1015. (IF: 6.922)

27.   ZhuangCL, Zhang FM, Xu HX,Weng M, Yao Y, Zhou FX, Li ZN, Guo ZQ, Li T, Li W, Shi HP;Investigationon Nutrition Status and Clinical Outcome of Common Cancers(INSCOC) Group.Reference values of low body mass index, mid-upper armcircumference, and calfcircumference in cancer patients: A nationwidemulticenter observational study.Nutrition. 2022 Jul-Aug;99-100:111688. (IF:4.008)

28.   LiuXY, Zhang X, Zhang Q, XieHL, Ruan GT, Liu T, Song MM, Ge YZ, Xu HX, Song CH,Shi HP. Value of theControlling Nutritional Status score in predicting theprognosis of patientswith lung cancer: A multicenter, retrospective study. JPENJ Parenter EnteralNutr. 2022 Aug;46(6):1343-1352. (IF: 4.016)

29.   LiY, Wang WB, Yang L, Wang QY,Dai J, Xia L, Peng J, Zhou FX, Wei YC, Shi HP. Thecombination of bodycomposition conditions and systemic inflammatory markers hasprognostic valuefor patients with gastric cancer treated with adjuvantchemoradiotherapy.Nutrition. 2022 Jan;93:111464. (IF: 4.008)

30.   XieH, Ruan G, Wei L, Zhang H,Ge Y, Zhang Q, Lin S, Song M, Zhang X, Liu X, Yang M,Tang M, Song CH, Deng L, ShiH. Comprehensive comparison of the prognostic valueof systemicinflammation biomarkers for cancer cachexia: a multicenterprospective study.Inflamm Res. 2022 Aug 13. (IF: 4.575)

31.   SongM, Liu T, Liu H, Zhang Q,Zhang Q, Wang Y, Ma X, Cao L, Shi H. Associationbetween metabolicsyndrome, C-reactive protein, and the risk of primary livercancer: a largeprospective study. BMC Cancer. 2022 Aug 4;22(1):853. (IF: 4.430)

32.   JiaP, Zhang Y, Xu J, Zhu M,Peng S, Zhang Y, Zhao J, Li X, Mi K, Yan D, Wang Y, YuL, Lu Y, Shi H,Cen S. IMB-BZ as an Inhibitor Targeting ESX-1 Secretion Systemto ControlMycobacterial Infection. J Infect Dis. 2022 Feb 15;225(4):608-616.(IF: 5.226)

33.   YinL, Song C, Cui J, Lin X, LiN, Fan Y, Zhang L, Liu J, Chong F, Wang C, Liang T,Liu X, Deng L, Yang M, YuJ, Wang X, Liu X, Yang S, Zuo Z, Yuan K, Yu M, Cong M,Li Z, Weng M, Yao Q, JiaP, Li S, Guo Z, Li W, Shi H, Xu H. De novo Creation andAssessment of aPrognostic Fat-Age-Inflammation Index "FAIN" inPatients With Cancer:A Multicenter Cohort Study. Front Nutr. 2022 Apr13;9:860285. (IF: 6.576)

34.   YinL, Zhang L, Li N, Guo J,Liu L, Lin X, Fan Y, Liu J, Zhang M, Chong F, Chen X,Wang C, Wang X, Liang T,Liu X, Deng L, Li W, Yang M, Yu J, Wang X, Liu X, YangS, Zuo Z, Yuan K, Yu M,Song C, Cui J, Li S, Guo Z, Shi H, Xu H. Severalanthropometricmeasurements and cancer mortality: predictor screening,thresholddetermination, and joint analysis in a multicenter cohort of 12138adults. EurJ Clin Nutr. 2022 May;76(5):756-764. (IF: 4.016)

35.   ZhuangCL, Dong QT, Shi HP,Zhang FM, Luo X, Wang WB, Yu Z, Chen XL, Wang SL. CachexiaVersus Sarcopenia inClinical Characteristics and Prognostic Value After RadicalGastrectomy forGastric Cancer: A Large-Scale Prospective Study. Ann Surg Oncol.2022Apr;29(4):2348-2358. (IF: 5.344)

36.   YinL, Song C, Cui J, Wang N,Fan Y, Lin X, Zhang L, Zhang M, Wang C, Liang T, Ji W,Liu X, Li W, Shi H,Xu H; Investigation on Nutrition Status and Clinical Outcomeof Common Cancers(INSCOC) Group. Low fat mass index outperforms handgripweakness andGLIM-defined malnutrition in predicting cancer survival: Derivationof cutoffvalues and joint analysis in an observational cohort. Clin Nutr.2022Jan;41(1):153-164. (IF: 7.324)

37.   YinL, Fan Y, Lin X, Zhang L,Li N, Liu J, Guo J, Zhang M, He X, Liu L, Zhang H, ShiM, Chong F, Chen X, WangC, Wang X, Liang T, Liu X, Deng L, Li W, Song C, Cui J,Shi H, Xu H;Investigation on Nutrition Status and Clinical Outcome of CommonCancers(INSCOC) Group. Fat mass assessment using the triceps skinfoldthicknessenhances the prognostic value of the Global Leadership InitiativeonMalnutrition criteria in patients with lung cancer. Br J Nutr. 2022May28;127(10):1506-1516. (IF: 3.718)

38.   XueH, Du H, Xie Y, Zhai Y,Song S, Luo B, Qiu H, Wang K, Cui J, Song C, Xu H, Li W,Shi H, Li Z;Investigation on Nutrition Status and Its Clinical Outcome ofCommon Cancers(INSCOC) Group. Association Between Fat Mass to Lean Body MassRatio andAll-Cause Mortality Among Middle-Aged and Elderly Cancer PatientsWithoutObesity: A Multi-Center Observational Study in China. Front Nutr. 2022Jun16;9:914020. (IF: 6.576)

编写专业著作57部，其中主编29本，主编包括：

《围手术期病理生理与临床》（人民卫生出版社）

《肿瘤营养学》（人民卫生出版社）

《营养筛查与评估》（人民卫生出版社）

《肿瘤恶液质》（人民卫生出版社）

《中国肿瘤营养治疗指南》（人民卫生出版社）

《蛋白质临床应用》（人民卫生出版社）

《临床营养操作规程》（人民卫生出版社）等

创作散文（随笔）215篇，出版散文集5本：

《映秀日记》（广东人民出版社）

《医怀天下》（广东人民出版社）

《医者禅心》（广东人民出版社）

《故乡越来越遥远》（广东人民出版社）

《对雪》（广东人民出版社）

获”全国优秀科技工作者“荣誉称号

获全国“荣耀医者”公益评选活动“专科精英奖”

获全国肿瘤患者“心目中的好医生”奖

科学中国人 2017年度人物

第十二届健康中国（2019年度）十大人物。

第二届国家名医盛典“国之名医•卓越建树”奖

获 “敬祐生命• 荣耀医者：科普影响力奖“

2018年、2021年度健康传播影响力人物

被评为全世界（国际）营养学研究领域最为活跃的5位学者之一，列第二位。

（五位分别是 美国兰克利夫兰诊所的 Rieder， Florian；中国首都医科大学附属北京世纪坛医院的 Shi， Hanping；法国巴黎Pitie-Salpetriere Hospital的 Clemente，Karine；世界卫生组织营养与食品安全部的 Branca，Francesco；瑞士Bern University Hospital的 Stanga，Zeno；《美国Healsan Consulting LLC; Stork》）

Journal of Nutritional Oncology                                                            主编

Precision Nutrition                                                                                主编

《医学参考报—营养学频道》                                                               主编

《肿瘤代谢与营养电子杂志》                                                               主编

中国抗癌协会肿瘤营养专业委员会                                                        主任委员

中国营养保健食品协会                                                                          副会长

中华医学会肠外肠内营养学分会第五届委员会                                      主任委员

中国抗癌协会学术部　　　　　　　　　　　　　　　　　　　          部长

主攻方向：盆腔廓清、癌性肠梗阻、肿瘤营养代谢治疗

首创腹膜外保功能盆腔廓清术，极大地改善了肿瘤患者生活质量、提高了手术安全与效果。创立我国肿瘤营养学科，提出肿瘤营养疗法、肿瘤代谢调节治疗、营养不良三级诊断、营养不良四维度分析、营养不良五阶梯治疗、医院-社区-家庭（H-C-H）分级营养治疗、整体营养疗法、营养治疗疗效综合评价、肿瘤患者营养教育。